BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 23733756)

  • 1. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy.
    Hershman DL; Unger JM; Crew KD; Minasian LM; Awad D; Moinpour CM; Hansen L; Lew DL; Greenlee H; Fehrenbacher L; Wade JL; Wong SF; Hortobagyi GN; Meyskens FL; Albain KS
    J Clin Oncol; 2013 Jul; 31(20):2627-33. PubMed ID: 23733756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715).
    Hershman DL; Unger JM; Crew KD; Till C; Greenlee H; Minasian LM; Moinpour CM; Lew DL; Fehrenbacher L; Wade JL; Wong SF; Fisch MJ; Lynn Henry N; Albain KS
    J Natl Cancer Inst; 2018 Jun; 110(6):669-676. PubMed ID: 29361042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer.
    Greenlee H; Crew KD; Capodice J; Awad D; Buono D; Shi Z; Jeffres A; Wyse S; Whitman W; Trivedi MS; Kalinsky K; Hershman DL
    Breast Cancer Res Treat; 2016 Apr; 156(3):453-464. PubMed ID: 27013473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial.
    Shimozuma K; Ohashi Y; Takeuchi A; Aranishi T; Morita S; Kuroi K; Ohsumi S; Makino H; Katsumata N; Kuranami M; Suemasu K; Watanabe T; Hausheer FH
    Support Care Cancer; 2012 Dec; 20(12):3355-64. PubMed ID: 22584733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathy.
    Campone M; Berton-Rigaud D; Joly-Lobbedez F; Baurain JF; Rolland F; Stenzl A; Fabbro M; van Dijk M; Pinkert J; Schmelter T; de Bont N; Pautier P
    Oncologist; 2013; 18(11):1190-1. PubMed ID: 24105751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients.
    Bao T; Seidman AD; Piulson L; Vertosick E; Chen X; Vickers AJ; Blinder VS; Zhi WI; Li Q; Vahdat LT; Dickler MN; Robson ME; Mao JJ
    Eur J Cancer; 2018 Sep; 101():12-19. PubMed ID: 30007894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02.
    Shimozuma K; Ohashi Y; Takeuchi A; Aranishi T; Morita S; Kuroi K; Ohsumi S; Makino H; Mukai H; Katsumata N; Sunada Y; Watanabe T; Hausheer FH
    Support Care Cancer; 2009 Dec; 17(12):1483-91. PubMed ID: 19330359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized adaptive selection trial of cryotherapy, compression therapy, and placebo to prevent taxane-induced peripheral neuropathy in patients with breast cancer.
    Accordino MK; Lee S; Leu CS; Levin B; Trivedi MS; Crew KD; Kalinsky K; Raghunathan R; Faheem K; Harden E; Taboada A; de Oliveira BD; Larson E; Franks L; Honan E; Law C; Hershman DL
    Breast Cancer Res Treat; 2024 Feb; 204(1):49-59. PubMed ID: 38060077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review.
    De Grandis D
    CNS Drugs; 2007; 21 Suppl 1():39-43; discussion 45-6. PubMed ID: 17696592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial.
    Lu W; Giobbie-Hurder A; Freedman RA; Shin IH; Lin NU; Partridge AH; Rosenthal DS; Ligibel JA
    Oncologist; 2020 Apr; 25(4):310-318. PubMed ID: 32297442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study.
    Greenlee H; Hershman DL; Shi Z; Kwan ML; Ergas IJ; Roh JM; Kushi LH
    J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 27794123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
    Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
    Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy-induced peripheral neuropathy in newly diagnosed breast cancer survivors treated with taxane: a prospective longitudinal study.
    Wang YJ; Chan YN; Jheng YW; Wu CJ; Lin MW; Tseng LM; Tsai YF; Liu LC
    Support Care Cancer; 2021 Jun; 29(6):2959-2971. PubMed ID: 33025227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy.
    Kotaka M; Saito Y; Kato T; Satake H; Makiyama A; Tsuji Y; Shinozaki K; Fujiwara T; Mizushima T; Harihara Y; Nagata N; Kurihara N; Ando M; Kusakawa G; Sakai T; Uchida Y; Takamoto M; Kimoto S; Hyodo I
    Cancer Chemother Pharmacol; 2020 Nov; 86(5):607-618. PubMed ID: 32965539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled pilot trial (NEUROLASER trial).
    Joy L; Jolien R; Marithé C; Stijn E; Laura S; Hilde L; Sandra B; Wendy N; Ruth H; Liesbeth R; Sylvana S; Sylvia H; Jeroen M
    Support Care Cancer; 2022 Jun; 30(6):5509-5517. PubMed ID: 35312857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study.
    Zirpoli GR; McCann SE; Sucheston-Campbell LE; Hershman DL; Ciupak G; Davis W; Unger JM; Moore HCF; Stewart JA; Isaacs C; Hobday TJ; Salim M; Hortobagyi GN; Gralow JR; Budd GT; Albain KS; Ambrosone CB
    J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29546345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial using surgical gloves to prevent chemotherapy-induced peripheral neuropathy by paclitaxel in breast cancer patients (AIUR trial).
    Kang YJ; Yoon CI; Yang YJ; Baek JM; Kim YS; Jeon YW; Rhu J; Yi JP; Kim D; Oh SJ
    BMC Cancer; 2023 Jun; 23(1):570. PubMed ID: 37340369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroacupuncture use for treatment of taxane-induced peripheral neuropathy in patients with breast cancer: protocol for a pilot, randomised, blinded, sham-controlled trial (EA for CIPN).
    Choi V; Park SB; Lacey J; Kumar S; Heller G; Grimison P
    BMJ Open; 2024 Jan; 14(1):e076391. PubMed ID: 38195173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled study.
    Leal AD; Qin R; Atherton PJ; Haluska P; Behrens RJ; Tiber CH; Watanaboonyakhet P; Weiss M; Adams PT; Dockter TJ; Loprinzi CL;
    Cancer; 2014 Jun; 120(12):1890-7. PubMed ID: 24619793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.
    Sun Y; Shu Y; Liu B; Liu P; Wu C; Zheng R; Zhang X; Zhuang Z; Deng Y; Zheng L; Xu Q; Jiang B; Ouyang X; Gao J; Xu N; Li X; Jiang S; Liang C; Yao Y
    Exp Ther Med; 2016 Dec; 12(6):4017-4024. PubMed ID: 28105133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.